Gilgamesh Pharmaceuticals

📍 New York, United States🗓 Founded 2019👥 35 employees💰 Last funded Apr 2025
Pharmaceutical Manufacturing🌐 gilgameshpharmaceutical.com
Website LinkedIn
Gilgamesh is a clinical-stage biotech whose vision is to reshape how mental illnesses are treated by shifting away from symptom management to a focus on rapid-acting and durable therapies targeting the fundamental drivers of disease. We do this by designing best-in-class new chemical entities (NCEs) acting through proven mechanisms, which are optimized for safety, efficacy, and patient access
4
Total investors
3
Early stage
0
Mid stage
1
Late stage
2019
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
3
Turkey
1
Investor activity2020–2025 · investors recorded per year
2020320251
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Gilgamesh Pharmaceuticals?
Gilgamesh Pharmaceuticals has 4 investors on record on gritt.io, including 3 early-stage backers and 1 late-stage investors.
When did Gilgamesh Pharmaceuticals last raise funding?
The most recent investment in Gilgamesh Pharmaceuticals recorded on gritt.io was in April 2025.
When was Gilgamesh Pharmaceuticals founded?
Gilgamesh Pharmaceuticals was founded in 2019.
What industry is Gilgamesh Pharmaceuticals in?
Gilgamesh Pharmaceuticals operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Gilgamesh Pharmaceuticals based?
Gilgamesh Pharmaceuticals is headquartered in New York, United States.